The human case for supporting cancer survivors is obvious. The financial case is just as compelling — and far less understood.
The support works. The gap is that most survivors never receive it in any structured form — and most employers don't know how to provide it. That is the problem Life|After® is built to solve.
Yet 50% of cancer patients are afraid to tell their employer about their diagnosis at all. The need is present in every workforce. It simply doesn't announce itself.
70% of cancer survivors remain employed through the first year after diagnosis. By year five, that number drops to 51%. The return happens. The sustained return — without structured support — often doesn't. That is the window Life|After® is built for.
PMC · Life Expectancy and Return to Work Among Cancer Survivors
Understanding why this happens — and what to do about it — is the subject of our article The 6-Month Wall →
A sample of what survivors are actually managing
Nearly every cancer survivor returns to the workplace managing some combination of these conditions — and often others not listed here. Dental complications, cardiovascular effects, sexual health changes, and other treatment side effects are equally real. These four represent the most documented workplace impacts. They are not rare complications. They are the norm — and most employers have no structured process for addressing any of them.
The question was never whether a returning survivor is struggling.
The question is whether anyone is helping them.
The replacement cost reality
Most employers think about cancer leave in terms of disability premiums and short-term productivity impact. What they underestimate is the cost of a failed return — when a valuable, tenured employee leaves the workforce entirely because the transition back wasn't supported.
The Society for Human Resource Management estimates it costs six to nine months of an employee's salary to replace them. For tenured professionals — teachers, administrators, nurses, engineers — that number climbs further when institutional knowledge is factored in.
The table to the right illustrates the typical cost structure for replacing a single employee at a $75,000 salary. It is not hypothetical — each line item is derived from published workforce research.
Based on a $75,000 annual salary. Source: SHRM, Gallup, Workable. Actual costs vary by role, industry, and tenure.
The productivity gap
Most return-to-work processes treat medical clearance as the endpoint. It isn't. Research consistently shows that cancer survivors experience ongoing functional limitations — fatigue, cognitive changes, pain, and emotional adjustment — that persist well into the return-to-work period. Without structured support, these limitations translate directly into extended productivity loss and increased risk of failed return.
Phase 1
Employee on leave. Disability claim active. Employer absorbs absence cost and begins managing coverage arrangements.
Phase 2
Physician clears employee to return. Most programs treat this as the finish line. The employee — and the real work — is just beginning.
Phase 3 — The gap
Without structured support, survivors return to work still managing fatigue, cognitive changes, and pain — conditions that show up as presenteeism, accommodation missteps, and failed returns. The cost accumulates here.
Phase 4
With the right support, the employee reaches sustained, productive return. Without it, the cycle restarts — or ends in separation.
"Life|After® operates in Phase 3 — the gap between medical clearance and genuine workforce readiness that existing benefit programs leave unmanaged. That is precisely where the cost accumulates, and where the program intervenes."
Beyond the financial cost
When an employee returns after cancer treatment without structured support, the gaps don't just show up in productivity numbers. They show up in accommodation decisions made informally, in processes that weren't documented, and in situations that escalate because no one had a clear plan.
Life|After® provides a structured, documented care coordination process — with senior oversight review at every assessment stage — that creates a clear record of what was done, when, and why. That record protects the employee and the employer alike.
Life|After® helps employers identify and implement appropriate workplace accommodations for returning survivors — based on actual needs assessment, not guesswork. Every recommendation is documented.
Ad hoc return-to-work decisions create inconsistency across employees and situations. Life|After® brings a structured, repeatable process that treats every case with the same standard of care.
Every assessment, recommendation, and care coordinator action is documented — giving HR a clear record of the return-to-work process that supports good decision-making and organizational accountability.
When an employer has followed a structured, documented process, they can stand behind the decisions they made. Life|After® is designed to give employers that confidence — not as a legal strategy, but as a standard of care.
The Life|After® difference
The contrast between a managed and an unmanaged return is not subtle. It shows up in disability duration, accommodation quality, legal exposure, and ultimately whether the employee comes back at all.
Life|After® operates on a pay-per-employee model — no retainer, no fixed overhead, cost incurred only when a case is active. Survivors are already in your workforce, already navigating this quietly. The need doesn't announce itself. For most employers, a single avoided replacement offsets the program cost four times over — conservatively. A shortened disability claim achieves a similar return. That is not a projection. It is arithmetic.
Interactive tool
Adjust headcount, active cases, and salary — the calculator shows your estimated exposure range based on published third-party research. No pricing shown.
| Post-Treatment Cost Path | Expected Cost | ||
|---|---|---|---|
|
Path A
Survivor does not return
Replacement only: recruiting, onboarding, lost institutional knowledge. Scaled to role salary at 50%–150%.
Sources: SHRM · JCO PMC6992498
|
— | ||
|
Path B
Survivor returns to work
Combined post-treatment cost: re-integration, delayed return, absenteeism & presenteeism — expressed as one researched range per survivor. Not stacked independent events.
Sources: CDC MEPS PMC5779368 · JNCI PMC7745836 · Frontiers PMC9039203 · PMC4642612
|
— | ||
|
Caregivers
Co-worker caregiver presenteeism
Entirely separate employee population. ~23% mean productivity loss per caregiver annually. Not a survivor cost — a distinct parallel impact.
Source: PMC4381346
|
— | ||
|
Total Expected Post-Treatment Cost
Path A and Path B are mutually exclusive — each survivor follows exactly one path.
|
— | ||
Next step
A 20-minute conversation is enough to understand whether the program is a fit for your organization or your clients. No commitment required.
Call direct
(877) 752-3837
Someone from our team will be in touch
info@lifeafter.net
Someone from our team will be in touch
For brokers
CDC/MMWR — Medical Costs and Productivity Losses of Cancer Survivors, United States 2008–2011. ·
Medical Expenditure Panel Survey (MEPS) — Experiences with Cancer Survivorship Survey, 2011. ·
Journal of Oncology Practice — Employer Paid Sick Leave, Disability, and Workers' Compensation Trends for Employees with Cancer Conditions. ·
SHRM — Employee Replacement Cost Benchmarks. ·
Gallup — State of the Global Workplace / Employee Replacement Cost Estimates. ·
PMC Systematic Review — Effect of Cancer Treatment on Work Productivity of Patients and Caregivers.
Life|After® makes no specific outcome guarantees. All cost estimates are derived from published third-party research and are illustrative of typical employer experience. Individual results vary by organization, employee, diagnosis, and role.
